Latest antibodies Stories
LA JOLLA, Calif.
New antibodies generated with RuiYi's iCAPS technology to explore GPCR structure and function LA JOLLA, Calif.
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
BREDA, the Netherlands, GHENT, Belgium and WHITE PLAINS, New York, June 10, 2014 /PRNewswire/ -- arGEN-X, a clinical stage biopharmaceutical company focused on creating
MELBOURNE, Australia, June 5, 2014 /PRNewswire/ -- Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01,
MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material -
BREDA, the Netherlands, June 4, 2014 /PRNewswire/ -- SIGNIFICANTLY EXPANDED RELATIONSHIP CREATED ON BACK OF COLLABORATION SUCCESS arGEN-X, a clinical-stage
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MONROVIA, Calif., May 28, 2014 /PRNewswire/ -- Xencor, Inc.
BREDA, The Netherlands, May 28, 2014 /PRNewswire/ -- arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies
- A trick or prank.
More Images (1 images) »